Roy Kaplan
Rheumatology · Encinitas, CANPI 1215962451
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Amgen at 58.1% of the total. Reporting peaked in 2019 at $54,003 and has fallen 99.5% since, to $268 in 2025. Among rheumatology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 206 payments — averaging $307.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$37K
- Bristol Myers Squibb$25K
- Janssen Scientific Affairs, LLC$462
- Novartis$255
- Pfizer$253
- UCB, Inc.$204
- plus $858 from 10 others
What the payments were for
- Consulting fees$14,31323%
- Speaking & faculty fees$32,91452%
- Travel & lodging$11,31118%
- Food & beverage$4,7498%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 74 | $36,738 |
| Bristol Myers Squibb | 48 | $24,517 |
| Janssen Scientific Affairs, LLC | 4 | $462 |
| Novartis | 12 | $255 |
| Pfizer | 20 | $253 |
| UCB, Inc. | 4 | $204 |
| AbbVie | 4 | $172 |
| Genentech USA, Inc. | 10 | $172 |
| Lilly USA, LLC | 9 | $143 |
| Sanofi | 1 | $125 |
| Johnson & Johnson | 12 | $90 |
| Mallinckrodt Enterprises LLC | 2 | $63 |
| Merck | 2 | $30 |
| Medexus Pharma, Inc. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$63,287 in reported general payments places this provider in the 90th percentile of 808 rheumatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $210,185 |
| Teriparatide | 14 | $30,229 |
| Leucovorin Calcium | 19 | $302 |
| Prednisone | 21 | $131 |
| Methotrexate SodiumMethotrexate Sodium/Pf | 11 | $111 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Encinitas
- Sudhakar TumuluriSan Francisco$2.8M
- Ara DikranianSan Diego$2.2M
- Orrin TroumSanta Monica$1.8M
- Robin DoreTustin$1.5M
- Samy MetyasCovina$1.3M
- Rhonda LambertSan Mateo$1.1M
- William ShielMission Viejo$924K
- Mark BoriginiDowney$920K
- Adam KreitenbergTarzana$863K
- Roger KornuTustin$802K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.